In 2021, GSK will produce one billion doses of coronavirus vaccine booster - British Herald
October 3, 2022
Business

In 2021, GSK will produce one billion doses of coronavirus vaccine booster

(Business) – GlaxoSmithKline Plc plans to expand vaccine efficacy boosters’ production to produce one billion doses in 2021 for use in shots for COVID-19.

GSK is in talks with governments on support for this programme to allow for a scaling up future successful vaccine production for COVID-19.

GSK is working on its own COVID-19 vaccine with Sanofi.

GSK’s adjuvant is said to be able to reduce vaccine protein required per dose to allow for the production of more vaccine.

Experts believe that the development of a successful vaccine will take over a year. Several companies and governments are funding many programmes as the only viable solution that will allow the world to escape durably from coronavirus lockdowns to get economies restarted.

(Photo syndicated via Reuters)
This story has been edited by BH staff and is published from a syndicated field.

Follow Me:

Related Posts